CX NEWS
CX 2018: Podium 1st presentations
In addition to the plethora of late-breaking trials that were unveiled at this year's Symposium, there was a vast array of Podium 1st presentations. These presentations showcased novel techniques and technologies, provided further insights [...]
CX Abstract and Poster Prize winners announced!
Poster prize winner Wei-Wen Ang with CX Abstract Board and Poster member Anna Prent At CX 2018, abstracts were presented—across 17 sessions—on the five programme areas of CX: Acute stroke, Thoracic Aortic [...]
CX 2018 in numbers
CX 2018 in numbersThis year's CX welcomed more than 4,000 participants at Olympia London from a record-breaking 86 countries. See the full stats and highlights in the video above.
One-year outcomes of EndoAnchor study adds ESAR—endosuture aneurysm repair—to the endovascular lexicon
Frank Arko Frank Arko (Charlotte, USA) presented one-year results from the 70-patient short-neck cohort of the ANCHOR Registry. Patients were treated with an endograft and endoanchors (Endurant and Heli-FX, Medtronic) for abdominal [...]
Low early mortality and high technical success for novel thoracic stent graft
A physician-sponsored investigational device exemption trial on thoracic endovascular aortic repair (TEVAR) using a new thoracic stent graft (Valiant thoracoabdominal aortic aneurysm stent graft, Medtronic), along with its initial 30-day data, was revealed at [...]
First case experience presented with next generation conformable EVAR device
CX delegates were presented data from the first 10 EVAR patients treated using a new conformable device, the Gore Excluder conformable abdominal aortic aneurysm endoprosthesis with active control system, yesterday. Robert Rhee (Brooklyn, New [...]
